;
MRI DYE CONTAINING GADOLINIUM
Intro
Symptoms
FDA
COI
COI Continued
Research
Steps
Patient Perspective
Etc.
Blog
Kenneth R. Maravilla
University of Washington
SERVED AS A CONSULTANT FOR GUERBET AND BRACCO; RECEIVED SUPPORT FOR TRAVEL FROM GUERBET AND BRACCO. INSTITUTION RECEIVED RESEARCH GRANTS FOR GUERBET AND PHILIPS.
RSNA 2015 PRESENTER "DO MACROCYCLIC GADOLINIUM BASED CONTRAST AGENTS(GBCA) DEPOSIT GD IN NORMAL BRAIN TISSUE IN PATIENTS RECEIVING CONTRAST ENHANCED MRI?"
RSNA 2016 SPEAKER ON NEURORADIOLOGY
RSNA 2017 PRESENTER
"GD DEPOSITS IN MULTIPLE ORGANS OF ADULT PATIENTS WITH NORMAL RENAL FUNCTION AFTER ADMINISTRATION OF GADOLINIUM CONTRAST AGENTS (GBCAS)"
RSNA 2018 PRESENTER "THE CORRELATION OF GD DEPOSITION WITH ADMINISTRATION OF GBCAS AND THE ELIMINATION RATES IN HUMAN BRAIN, BONE, AND SKIN"
CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS (CMSC) 2017 ANNUAL MEETING
PRESENTER "GADOLINIUM ACCUMULATION IN THE BODY"
ASNR FOUNDATION DONOR
MRI safety, MRI side effects, Gadolinium, Toxic, MRI Contrast, MRI Dye, Safety, GBCA, NSF, ACR, Fibromyalgia, Radiology, Linear, Macrocylic, CTE, Football CTE, Chronic Traumatic Encephalopathy, multiple sclerosis, brain injury